Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The fair market value of TRTC is zero because it is unable to produce net profit.
However, thanks to certain individuals with dogged persistency on this board and company's history of putting out hypes, they've created virtual value for TRTC (from artificially inflated stock PPS) that far exceeds company's revenue in its short operating history.
The downside of this liquidity is that TRTC's PPS is subject to sudden and violent drops for it is mostly traded by flippers not investors.
Opening the first dispensary on Oregon's first day of legalization and the second two weeks later. IMO, the CEO certainly deserve his 200K salary.
We shall see if they open the third or even fourth dispensaries before TRTC opens its first.
Of course, 233K+ of investors' money went to his own private grow operation and not reported in the financial. Crafty is the word I'd use.
No account receivable balance means those numbers cannot be trusted.
During the nine months ended September 30, 2015, our subsidiary, IVXX, purchased raw materials totaling $233,735 from an entity in which our Chief Executive Officer has an ownership interest. IVXX also sold finished goods amounting to $336,357 to that same entity. The terms of the purchases of the raw materials and sales of the finished goods were at arms-length. There was no accounts receivable balance from this entity as of September 30, 2015.
The future for company like TRTC isn't as rosy as most people here think.
TRTC isn't a Medical Marijuana company. It is a Recreational Marijuana Company.
To be a Medical Marijuana company, a simple extractor just won't cut it. TRTC would need Bio Pharmaceutical precision to produce medical grade marijuana drugs.
If they didn't do anything else but selling shares, they would have reported a profit.
Everything they do is at a cost.
Luckily I've significantly reduced my TRTC holding before the dump.
Unfortunately, TRTC executives do not value their stocks as much as investors do. They will continue to dilute to get more cash. To them, it's worth nothing until it's exchanged for cash.
Net loss on all operations. I thought they said EG is cash flow positive?
Couldn't understand net loss on IVXX either with all that profit margin.
What does it take for them to run an operation that bring in net profit?
The parallels of attacks on TRTC and Nobilus are astounding!
The problem with TRTC's story is that it is told by hypes. Imaging if all your "forward-looking statements" are actual verifiable PRs, the TRTC PPS would go much higher, instead we are seeing large selloff before earning.
Instead of hypes:
1) Entry into Maryland
2) IVXX for profit in 2016
3) Walmart expands EG further IMHO
4) Financing for Nevada in place !!!
5) Entry into New Jersey
6) Acquire BlumOak
7) Nasdaq listing !!!!!
8) No other public company in California !!!!
9) Sleek is never wrong
10)Neverselling needs a new cardboard box to live in !!!
Here is a supportive caution for longs...
Last time it dropped from 0.18 to 0.13 took only 2 days time. That is how dilution works - exchanging shares for cash with a unpredictable large selloff. The trick is to take profit before Magna does. that's right, you'll mostly likely be burned by holding when the stock is run on dilution and hypes.
Being innovative in technology means finding new economic solutions to a technical problem with maximum social benefits.
Being innovative in financing is to play at the boundary of law so that you maximize the amount of money you can lawfully get away with.
All TRTC board members have similar background in financing and they appreciate individuals with the same adventurous spirit at manipulating other people's money.
Thanks should go to Magna for holding back from selling shares into bids without constraints. However the relief may be temporary. MBAK is looming large just a tick above the ask.
Adding another finance expert to the board, TRTC is becoming a Financial Consulting Firm, And out of all that expertise is more toxic financing that continue to reduce shareholder value.
Outside investors would not invest in TRTC because they lack of true technical expertise to run a professional medical marijuana company.
Then my point is commoditization is good for shareholders and non-commoditization is good for general customers.
And I rather see IVXX get to the former first not the latter.
Bad comparison.
Pizza production is vastly automated with less quality control requirements in comparison to IVXX MJ extraction (pizza raw materials are all sourcing from same provider(s) under company's control).
IVXX extraction lab is currently mostly manually driven. And how do they preform quality control? MANUALLY collect samples from each batch and submit to a certified testing lab and wait?
Profit margin improves tremendously, only if production, Quality Control, and Packaging can all to automated in-house.
The trajectory of future PPS is all hinge on how many more shares Magna is going to release.
Remember after the news of two extra dispensary permits, TRTC PPS drop 30% in the following two weeks?
Even with increasing buy volume because future is bright, Magna dilution can dim that light pretty quickly.
Vote for Bernie Sanders is the most sane action you can do to help out USMJ than any ridiculous hypes on this board (including those from the company itself).
Sanders says he'd remove marijuana from federal drug list
sure, your wish is obviously their command.
Shares sold below bid is caused by selling large block at market price.
Those people you are referring to are Magna employees diluting for TRTC.
I guess they finally run out of patience after a week of self-restraint and decided to sell into bids at the end of day.
It's time for TRTC to find private investment going forward.
USPTO maintains two patent databases: One containing the final approved patents and the other existing patent applications that are put into a queue for examination on a first come first serve basis.
The NaturesComfortMeds patent is in the later not the former, therefore, it has not yet been approved. (you can find it in the application database using advance search term APN/182631 and AAST/RI)
Unfortunately, any one who filed provisional patent application is almost always guaranteed a spot in the applications database.
It will take at least another 2-4 years to get the final approval and, this time, it is not 100% guaranteed. They won't get the final approval, IF they cannot prove no prior art exists.
Knowing TRTC, if there is even a small insider buy, they would start a parade about it to incite investors' interests. So, I am pretty sure there is no recent insider buys.
I'd love someone prove me wrong though.
I don't mind the $10 land deal but I do have serious doubt on the IVXX revenue being pumped constantly to be millions while only one lab is active. We shall see how Q3 looks.
I happen to know intimately the entire process of applying for a patent.
USPTO maintains two patent databases: One containing the final approved patents and the other existing patent applications that are put into a queue for examination on a first come first serve basis.
The NaturesComfortMeds patent is in the later not the former, therefore, it has not yet been approved. (you can find it in the application database using advance search term APN/182631 and AAST/RI)
Unfortunately, any one who filed provisional patent application is almost always guaranteed a spot in the applications database.
It will take at least another 2-4 years to get the final approval and, this time, it is not 100% guaranteed. They won't get the final approval, IF they cannot prove no prior art exists.
The art of dilution is to blend in. If I can prove it, they did a terrible job. Although, the volume chart did show large sells from a few entities.
Hate to pull trampoline from underneath you jumping for joy, Level 2 indicates massive insider or dilutor sells that disappointingly offset all buys from the news release.
I've a even bigger news than yours and after that the biggest news in USMJ's short history. But not allowed to show off.
You spoke like you are the CFO of the company.
So far, according to them, the capital they have is enough for NV buildout not for IVXX expansion. How about money for the next 10 extractors? or for acquisition of CA, NJ, MI dispensaries?
For a company like TRTC, easy money comes from selling shares and the more the better.
If TRTC is currently lack of funding to expand, it needs to learn how to profit from a single operation and use that profit to bootstrap the next.
TRTC hasn't demonstrated the ability to bootstrap itself into profitability and relies heavily on selling shares.
Until this ability is demonstrated by a PR, investors are hesitant to put money into this bottomless pit whose PPS is dominated by financiers releasing shares.
IMO, "fluff" means a superficial statement having no substance. It's main purpose is to incite investors' interest to increase PPS.
In this case, a serious business would collect sale statistics across product profile at each dispensary. This study would help determine their manufacturing strategy to maximize profit margin.
This data is what I want to see in a PR, not a gross statement in a financial report on how much revenue IVXX has brought in. A simple accounting trickery could have created that revenue out of nowhere.
TRTC has a history of putting out fluff PRs.
The recent PRs about new dispensaries added are also fluff. We investors want to know how many and how quickly products are moving thru each dispensary at what average profit margin? Not how many dispensaries are available for distribution.
With all these delay, how would you gauge to what degree of efficiency has TRTC been spending minimum amount of investors' money possible to get maximum result? Based on all your DD, can you come up with an indicator that shows majority of our long-term investors' money is still in a bank account somewhere and not already been misappropriated.
re-evaluate the stock over time
The house always wins because they have control of large amount of capital, in this case, shares and they also have large number of participants in the market. By law of large number, they can control the accumulated mean profit overtime from selling / buying activities from all the participants.
WTF, of coarse it can!!!
Easy for you to say.
I am afraid TRTC management may buy many islands long before you ever do.
When the dilutors started selling in earnest, it was at 0.15. If this run can sustain beyond 0.15, I am convinced it is a reversal of some kind. Until then, it is still possible it is a dead cat bounce waiting for Magna to start selling the next batch of shares.
I am providing one simple possible sample path that poke hole in your statement and shows not all IVXX.LLC revenue can go back into IVXX development. This is not IN OUR CONTROL but company insiders', and we have no idea how they allocate or misappropriate assets.
The reason why it is called "fluff" is because it is a PR that no one can see and solicit no intended effect. I couldn't find it is exactly the evidence that it is fluff.
Your response makes no sense and therefore belongs to my WASTEBASKET.
Here is one that pops into my head immediately. Others will follow.
Can you find a printed Newsweeks magazine that contains The EARLY BIRD article that was prominently showing on TRTC facebook page?
I've searched on Newsweek.com website and found no mention of that article ever printed and officially distributed.
Are you with this board and TRTC long enough to come up a comprehensive list of all the PRs they put out over the last 2 years?
If yes, please share with us and check the ones that were clearly fluff. (other board memebers could help here also.)
By the end of this exercise, you will understand.